MAPPING THE LIGAND-BINDING SITE OF THE NK-1 RECEPTOR

被引:25
作者
FONG, TM
HUANG, RRC
YU, H
STRADER, CD
机构
[1] Department of Molecular Pharmacology and Biochemistry, Merck Research Laboratories, Rahway, NJ
关键词
SUBSTANCE-P; NEUROKININ; RECEPTOR; BINDING SITE; NONPEPTIDE ANTAGONIST;
D O I
10.1016/0167-0115(93)90010-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:43 / 48
页数:6
相关论文
共 28 条
[1]   A TACHYKININ PEPTIDE RECEPTOR JOINS AN ELITE CLUB [J].
BUCK, SH ;
PRUSS, RM ;
KRSTENANSKY, JL ;
ROBINSON, PJ ;
STAUDERMAN, KA .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1988, 9 (01) :3-5
[2]  
CASCIERI MA, 1986, MOL PHARMACOL, V29, P34
[3]  
CASCIERI MA, 1992, MOL PHARMACOL, V42, P458
[4]   ROLE OF LOOP HELIX INTERACTIONS IN STABILIZING 4-HELIX BUNDLE PROTEINS [J].
CHOU, KC ;
MAGGIORA, GM ;
SCHERAGA, HA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (16) :7315-7319
[5]   STRUCTURAL FEATURES REQUIRED FOR LIGAND-BINDING TO THE BETA-ADRENERGIC-RECEPTOR [J].
DIXON, RAF ;
SIGAL, IS ;
CANDELORE, MR ;
REGISTER, RB ;
SCATTERGOOD, W ;
RANDS, E ;
STRADER, CD .
EMBO JOURNAL, 1987, 6 (11) :3269-3275
[6]  
FONG TM, 1992, J BIOL CHEM, V267, P25668
[7]  
FONG TM, 1992, J BIOL CHEM, V267, P25664
[8]   THE EXTRACELLULAR DOMAIN OF THE NEUROKININ-1 RECEPTOR IS REQUIRED FOR HIGH-AFFINITY BINDING OF PEPTIDES [J].
FONG, TM ;
YU, H ;
HUANG, RRC ;
STRADER, CD .
BIOCHEMISTRY, 1992, 31 (47) :11806-11811
[9]  
FONG TM, 1992, MOL PHARMACOL, V41, P24
[10]  
FONT TM, 1992, BIOPHYS J, V62, P59